shkreli

Fed’s Lockhart: Two rate hikes this year ‘certainly possible’, flags Brexit risk

The United States could see two further interest rate rises this year but uncertainties abound including the impact on the U.S. economy should Britain vote to leave the European Union, Atlanta Fed President Dennis Lockhart said on Tuesday. On that front, Lockhart said that incoming data between now and the Fed's next meeting on June 14-15 “is not comprehensive by any stretch of the imagination” and that the upcoming Brexit vote in Britain raised risks. “It is…

Read more from the original source: 
Fed’s Lockhart: Two rate hikes this year ‘certainly possible’, flags Brexit risk

shkreli

Global factory growth nearly stalled in April: PMI

LONDON (Reuters) – Global manufacturing growth almost stalled last month as rising price halted a pick-up in new orders, a survey showed on Tuesday.

See the original post: 
Global factory growth nearly stalled in April: PMI

shkreli

New drugs fuel strong Pfizer results; company raises 2016 forecasts

Pfizer said sales would be hurt in the fourth quarter of 2016, however, when those added days will be offset by fewer days. Pfizer walked away from the deal after the U.S. Treasury issued new rules curbing tax inversion deals, under which American companies move overseas to cut taxes. Many analysts believe Pfizer needs to buy new medicines or entire biotech companies to ensure competitive earnings growth.

Read more here:
New drugs fuel strong Pfizer results; company raises 2016 forecasts

shkreli

U.S. prosecutors consider more charges against ex-CEO Shkreli

NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor

Read more from the original source: 
U.S. prosecutors consider more charges against ex-CEO Shkreli

shkreli

Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

By Sarah N. Lynch and David Ingram WASHINGTON/NEW YORK (Reuters) – Former drug executive Martin Shkreli smirked and brushed off questions about drug prices then tweeted that lawmakers were imbeciles on Thursday, when he appeared at a U.S. congressional hearing against his will. Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after his company, Turing Pharmaceuticals, raised the …

See more here:
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

shkreli

BMW hit with $40 million U.S. penalty for safety lapses

U.S. auto safety regulators on Monday fined BMW $10 million, part of a $40 million civil settlement over the German automaker's safety lapses. The fine is the second paid by BMW since 2012 and the latest in a series of civil penalties imposed on major automakers by the National Highway Traffic Safety Administration (NHTSA). Under the settlement, BMW admitted it did not comply with minimum crash protection standards…

Read more here: 
BMW hit with $40 million U.S. penalty for safety lapses

shkreli

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital…

See original here: 
KaloBios fires Shkreli as CEO

shkreli

Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’

Federal Reserve forecasts pointing to four interest rate hikes in 2016 show what the U.S. central bank means when it says it anticipates raising rates at a “gradual pace,” Richmond Fed President Jeffrey Lacker said on Friday.

See the rest here: 
Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’

shkreli

WTO backs agricultural reforms, split on Doha

By Edith Honan NAIROBI (Reuters) – The World Trade Organization reached deals on agricultural export subsidies, food aid and other issues on Saturday, capping a ministerial conference in the Kenyan capital where rich and poor countries had been split over

View post: 
WTO backs agricultural reforms, split on Doha

shkreli

Martin Shkreli says securities fraud charges are ‘baseless’

By Frank McGurty NEW YORK (Reuters) – Martin Shkreli, the pharmaceuticals entrepreneur vilified for jacking up the price of a life-saving AIDS drug, said on Saturday that unrelated securities fraud allegations that resulted in his arrest this week were “baseless and …

See the original post:
Martin Shkreli says securities fraud charges are ‘baseless’

Next Page »